NO20014718D0 - Formulering inneholdende testosteron-undekanoat og castorolje - Google Patents

Formulering inneholdende testosteron-undekanoat og castorolje

Info

Publication number
NO20014718D0
NO20014718D0 NO20014718A NO20014718A NO20014718D0 NO 20014718 D0 NO20014718 D0 NO 20014718D0 NO 20014718 A NO20014718 A NO 20014718A NO 20014718 A NO20014718 A NO 20014718A NO 20014718 D0 NO20014718 D0 NO 20014718D0
Authority
NO
Norway
Prior art keywords
castor oil
testosterone undecanoate
solution
liquid carrier
formulation containing
Prior art date
Application number
NO20014718A
Other languages
English (en)
Other versions
NO20014718L (no
NO329420B1 (no
Inventor
Henrik Nijs De
Susan Chandler
Elizabeth Anne Perry
Josephine Joan Chri Ferdinando
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20014718D0 publication Critical patent/NO20014718D0/no
Publication of NO20014718L publication Critical patent/NO20014718L/no
Publication of NO329420B1 publication Critical patent/NO329420B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
NO20014718A 1999-04-01 2001-09-28 Formulering inneholdende testosteron-undekanoat og lakserolje samt anvendelse av disse for fremstilling av medikament for behandling av sykdom NO329420B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99302581 1999-04-01
PCT/EP2000/002677 WO2000059512A1 (en) 1999-04-01 2000-03-27 Formulation comprising testosteron undecanoate and castor oil

Publications (3)

Publication Number Publication Date
NO20014718D0 true NO20014718D0 (no) 2001-09-28
NO20014718L NO20014718L (no) 2001-09-28
NO329420B1 NO329420B1 (no) 2010-10-18

Family

ID=8241306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014718A NO329420B1 (no) 1999-04-01 2001-09-28 Formulering inneholdende testosteron-undekanoat og lakserolje samt anvendelse av disse for fremstilling av medikament for behandling av sykdom

Country Status (27)

Country Link
EP (1) EP1189620B1 (no)
JP (1) JP2002541111A (no)
KR (1) KR100666016B1 (no)
CN (1) CN1155385C (no)
AT (1) ATE269708T1 (no)
AU (1) AU768537B2 (no)
BR (1) BR0009465A (no)
CA (1) CA2366856C (no)
CZ (1) CZ298573B6 (no)
DE (1) DE60011771T2 (no)
DK (1) DK1189620T3 (no)
ES (1) ES2222199T3 (no)
HK (1) HK1043544A1 (no)
HU (1) HU229455B1 (no)
ID (1) ID30481A (no)
IL (2) IL145524A0 (no)
MX (1) MXPA01009919A (no)
NO (1) NO329420B1 (no)
NZ (1) NZ514290A (no)
PL (1) PL195163B1 (no)
PT (1) PT1189620E (no)
RU (1) RU2246296C2 (no)
SK (1) SK286071B6 (no)
TR (1) TR200102769T2 (no)
TW (1) TWI280124B (no)
WO (1) WO2000059512A1 (no)
ZA (1) ZA200107781B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
GB9907715D0 (en) * 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
JO2505B1 (en) * 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
SI1530965T1 (sl) * 2003-11-11 2006-06-30 Mattern Udo Formulacija za nasalno aplikacijo z nadzorovanim sproscanjem spolnih hormonov
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
EP2979699A1 (en) * 2005-04-15 2016-02-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
ATE496617T1 (de) 2006-10-04 2011-02-15 M & P Patent Ag Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
ES2525520T3 (es) * 2010-04-12 2014-12-26 Clarus Therapeutics, Inc. Formulaciones orales de éster de testosterona y métodos para tratar la deficiencia de testosterona con las mismas
GB201006200D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
HUE037660T2 (hu) * 2011-01-26 2018-09-28 Allergan Inc Androgén készítmény szembetegség kezelésére
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
US9925200B2 (en) 2014-06-17 2018-03-27 Merck Sharp & Dohme B.V. Stable formulations of testosterone undecanoate
EA036836B1 (ru) * 2014-06-19 2020-12-25 Солурал Фарма Апс Фармацевтическая композиция для обеспечения лимфатической абсорбции липофильных соединений после еды и натощак
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160193225A1 (en) * 2014-08-29 2016-07-07 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
SE9700642D0 (sv) * 1997-02-24 1997-02-24 Kronvall Stefan Med Ab Medel och sätt för förebyggande och behandling av det metabola syndromet

Also Published As

Publication number Publication date
DE60011771T2 (de) 2004-11-04
CZ298573B6 (cs) 2007-11-14
SK286071B6 (sk) 2008-02-05
IL145524A0 (en) 2002-06-30
NZ514290A (en) 2003-08-29
WO2000059512A1 (en) 2000-10-12
EP1189620B1 (en) 2004-06-23
CA2366856A1 (en) 2000-10-12
AU768537B2 (en) 2003-12-18
PL195163B1 (pl) 2007-08-31
PT1189620E (pt) 2004-10-29
DK1189620T3 (da) 2004-08-16
PL351259A1 (en) 2003-04-07
IL145524A (en) 2006-12-31
CZ20013507A3 (cs) 2002-03-13
DE60011771D1 (de) 2004-07-29
HK1043544A1 (en) 2002-09-20
CN1155385C (zh) 2004-06-30
CA2366856C (en) 2006-05-16
NO20014718L (no) 2001-09-28
TR200102769T2 (tr) 2002-05-21
RU2246296C2 (ru) 2005-02-20
EP1189620A1 (en) 2002-03-27
ID30481A (id) 2001-12-13
CN1346274A (zh) 2002-04-24
ATE269708T1 (de) 2004-07-15
ES2222199T3 (es) 2005-02-01
KR100666016B1 (ko) 2007-01-10
NO329420B1 (no) 2010-10-18
TWI280124B (en) 2007-05-01
HUP0200453A3 (en) 2003-06-30
ZA200107781B (en) 2002-12-20
BR0009465A (pt) 2002-01-08
HU229455B1 (en) 2013-12-30
AU4111100A (en) 2000-10-23
HUP0200453A2 (hu) 2002-07-29
SK13722001A3 (sk) 2002-02-05
JP2002541111A (ja) 2002-12-03
MXPA01009919A (es) 2002-04-24
KR20010108435A (ko) 2001-12-07

Similar Documents

Publication Publication Date Title
NO20014718D0 (no) Formulering inneholdende testosteron-undekanoat og castorolje
RU2001129362A (ru) Композиция, включающая ундеканоат тестостерона и касторовое масло
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
CA2185347A1 (en) A carrier for hydrophobic drugs and a pharmaceutical composition based thereon
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
HUP0500843A2 (hu) Fokozott biológiai hasznosulású, szájon át hatásos taxánszármazékokat tartalmazó gyógyszerkészítmények
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
CA2431397A1 (en) Self emulsifying lipid matrix (selm)
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
MXPA04000535A (es) FORMULACIONES ANTIHISTAMINICAS PARA FORMAS DE DOSIFICACION DE CaPSULAS SUAVES.
STRICKLEY et al. Solubilizing vehicles for oral formulation development
MXPA05008921A (es) Formulaciones orales semisolidas para liberacion inmediata que comprenden un agente hidrofobo anticancer, un glicerido poliglicolisado y un vehiculo hidrofilo.
AR023235A1 (es) Formulaciones de androgenos
AU3043400A (en) Cyclosporin solution
US20060024341A1 (en) Microemulsion composition and related method
TH33003B (th) สูตรตำรับแอนโดรเจน
TH60756A (th) สูตรตำรับแอนโดรเจน
TH34374B (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
TH40043A (th) องค์ประกอบเชิงเภสัชกรรมชนิดที่เป็นของแข็งซึ่งประกอบด้วยอนุพันธ์เบนโซฟูแรน
TH41464A (th) สารผสมทางเภสัชกรรม
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP & DOHME BV, NL

MK1K Patent expired